An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody
- Status
- UNKNOWN
- Phase
- PHASE1
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
National Project on Vaccines, COVID-19 and Frail Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Magrolimab in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology
- Status
- COMPLETED
- Phase
- NA
Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1
Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
PF-07284892 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies
- Status
- RECRUITING
- Phase
- N/A
Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A